News
Ministerial evaluation
We are pleased to announce that the Polish Ministry of Education and Science (MEiN) has increased the number of points assigned to Advances in Clinical and Experimental Medicine from 70 to 140. This change reflects our continuous pursuit of quality in scientific publishing. The Editorial Team would like to thank Section Editors, whose commitment, experience and contribution have made this achievement possible.
https://www.gov.pl/web/edukacja-i-nauka/komunikat-ministra-edukacji-i-nauki-z-dnia-17-lipca-2023-r-w-sprawie-wykazu-czasopism-naukowych-i-recenzowanych-materialow-z-konferencji-miedzynarodowych
.png)
New call for submissions
Innovations in Therapeutic Interventions:
Advancing Clinical and Experimental Medicine
Handling Editors
Dr. Masaru Tanaka (ELKH-SZTE Neuroscience Research Group, Eötvös Loránd Research Network, University of Szeged (ELKH-SZTE), Hungary)
Dr. Simone Battaglia (Center for Studies and Research in Cognitive Neuroscience, Department of Psychology, University of Bologna, Italy
Dr. Francesco Di Gregorio (AUSL Bologna; Department of Psychology, University of Bologna, Italy)
Prof. Izabella Uchmanowicz (Wroclaw Medical University, Poland)
Prof. Donata Kurpas (Wroclaw Medical University, Poland)
Advances in Clinical and Experimental Medicine (Adv Clin Exp Med; IF 2.1, Scopus CiteScore 3.4) cordially invites you to contribute your valuable research to our esteemed journal. We are dedicated to promoting groundbreaking advancements in clinical and experimental medicine, focusing on emerging therapeutic strategies. We aim to enhance our impact factor and facilitate collaborations that drive progress in medicine.
We welcome reviews as well as original research articles and research letters in various clinical and experimental medicine areas. We encourage submissions on the following topics:
Precision Medicine and Personalized Therapies: Explore novel approaches in tailoring medical treatments based on an individual's genetic makeup, environmental factors, and disease characteristics. Highlight the potential of precision medicine in improving patient outcomes and overcoming treatment challenges. This topic includes but is not limited to:
Immunotherapy and Immunomodulation: Investigate the role of immunotherapy and immunomodulation in treating various diseases, including cancer, autoimmune disorders, and infectious diseases. Focus on cutting-edge techniques, therapeutic targets and potential synergies with other treatment modalities.
Gene and Cell Therapies: Present innovative research on gene and cell-based therapies, such as stem cell transplantation, gene editing and regenerative medicine. Explore their applications across different diseases and discuss their clinical implications and prospects.
Artificial Intelligence and Big Data Analytics in Medicine: Examine the integration of artificial intelligence (AI) and big data analytics in medical research, diagnostics, treatment optimization, and patient care. Highlight the potential of AI algorithms, machine learning and data-driven approaches in revolutionizing healthcare practices.
Digital Health Technologies and Wearables: Discuss the advancements in digital health technologies (including telemedicine), wearable devices and remote monitoring systems. Explore their impact on healthcare delivery, patient engagement, disease management, and prevention strategies.
All papers should focus on:
Translational Research and Bench-to-Bedside Innovations: Showcase translational research efforts that bridge the gap between laboratory discoveries and clinical applications. Present successful examples of bench-to-bedside innovations that have improved patient care and outcomes.
Keywords
therapeutic interventions; personalized therapies; immunotherapy; immunomodulation; gene and cell therapies; artificial intelligence; Big Data analytics; digital health technologies
By submitting your research to Adv Clin Exp Med, you will become an integral part of a dynamic and vibrant community of dedicated researchers committed to advancing the fields of clinical and experimental medicine. By undergoing our rigorous peer-review process, you can be assured that only high-quality and impactful studies are published, enhancing your professional reputation and contributing to advancing medical knowledge.
We look forward to receiving your submissions and collaborating to make a lasting impact on the field of clinical and experimental medicine.
Submission process
As a first step, we ask for submissions of an Expression of Interest with an Abstract of original papers outlining the themes above to Adv Clin Exp Med Managing Editor Marek Misiak: marek.misiak@umw.edu.pl
The Editor-in-Chief will review all submissions and select those invited to submit a full paper. The submission process will follow the regular Adv Clin Exp Med online process. All manuscripts will be sent to at least two independent reviewers.
Dates and fees
Submission of Expression of Interest until January 31, 2024, to the ACEM Managing Editor: marek.misiak@umw.edu.pl
Invitation to submit the full paper by March 1, 2024;
Submission of full paper by June 30, 2024.
If accepted, Authors will be required to pay a fee to cover publication costs (https://advances.umw.edu.pl/en/article-processing-charges/). For selected Authors (outstanding experts), reducing or even cancelling the publication fee is possible.
We look forward to a wide variety and genuinely global collection of papers and experiences to push worldwide science to the next level!
5th International Wroclaw Scientific Meetings
The journal Advances in Clinical and Experimental Medicine has taken patronage over 5th International Wroclaw Scientific Meetings – an event organized by the scientists from Faculty of Pharmacy of Wroclaw Medical University. It will be held at Wroclaw Medical University, Faculty of Pharmacy, ul. Borowska 211A, on October 19–21, 2023.
The conference is addressed to young researchers. It is a unique opportunity to present their work in the field of pharmacy, biology, medicine, toxicology, engineering, and technology.
5th International Wroclaw Scientific Meetings is in memoriam of Prof. Jolanta Saczko (1964–2023) who has made an important contribution to the field of experimental anticancer therapies, and has been the mentor and the inspiration for young scientists.
Our aim is to spread and exchange the knowledge among young scientists.
MORE INFORMATION:
https://konferencje.umw.edu.pl/5iwsm2023/
New Impact Factor
We proudly announce that our Impact Factor has increased from 1.736 (2021) to 2.1 (2022), while the 5-Year Impact Factor has risen from 2.1 to 2.2. It clearly shows that our position within the scientific journals’ community has strengthened – we publish more and more cutting-edge research and our papers are cited in other prestigious scientific journals. We are striving and will be striving to make it even higher!
Special thanks go to all our authors, reviewers and section editors, whose hard work, commitment and competence have made this achievement possible. Disseminating science is a mission; the journal Advances in Clinical and Experimental Medicine is a part of a great project of making people in the whole world healthier and happier!
Professor Jolanta Saczko is no longer with us
All members of the Editorial Committee and Editorial Board of Advances in Clinical and Experimental Medicine are deeply saddened by the news of Professor Jolanta Saczko’s passing on June 23, 2023. She was one of our Section Editors and our mainstay – committed, patient and extremely competent. On behalf of all abovementioned members, we extend our heartfelt condolences to the family, friends, and loved ones of Professor Saczko. We know that words can give little consolation to relieve grief but we should like you to know that we too will be grieving for her.
She will be greatly missed, but her legacy will live on for many years to come.
In deepest sympathy,
Prof. Donata Kurpas
Editor-in-Chief
Prof. Wojciech Kosmala
Deputy Editor
members of the Editorial Committee of Advances in Clinical and Experimental Medicine
members of the Editorial Board of Advances in Clinical and Experimental Medicine
Seamus Heaney
The Blackbird of Glanmore
On the grass when I arrive,
Filling the stillness with life,
But ready to scare off
At the very first wrong move.
In the ivy when I leave.
It’s you, blackbird, I love.
I park, pause, take heed.
Breathe. Just breathe and sit
And lines I once translated
Come back: “I want away
To the house of death, to my father
Under the low clay roof.”
And I think of one gone to him,
A little stillness dancer—
Haunter-son, lost brother –
Cavorting through the yard,
So glad to see me home,
My homesick first term over.
And think of a neighbour’s words
Long after the accident:
“Yon bird on the shed roof,
Up on the ridge for weeks—
I said nothing at the time
But I never liked yon bird.”
The automatic lock
Clunks shut, the blackbird’s panic
Is shortlived, for a second
I’ve a bird’s eye view of myself,
A shadow on raked gravel
In front of my house of life.
Hedge-hop, I am absolute
For you, your ready talkback,
Your each stand-offish comeback,
Your picky, nervy goldbeak—
On the grass when I arrive,
In the ivy when I leave.
.jpg)
New CiteScore
We proudly inform our readers that our Scopus CiteScore has increased from 3.0 for 2021 to 3.4 for 2022. Our current Scimago Journal Rank (SJR) is 0.449 and Source Normalized Impact Paper (SNIP) is 0.646. Steadily rising bibliometric scores of Advances in Clinical and Experimental Medicine confirm our expanding influence among scientific medical journals.
.png)
DORA
ACEM is a signatory of San Francisco Declaration on Research Assessment (DORA), which intends to halt the practice of correlating the journal impact factor to the merits of a specific scientist's contributions. Such practice creates biases and inaccuracies when appraising scientific research. It also states that the impact factor is not to be used as a substitute measure of the quality of individual research articles, or in hiring, promotion, or funding decisions. It has become a worldwide initiative covering all scholarly disciplines and all key stakeholders including funders, publishers, professional societies, institutions, and researchers. We encourage all individuals and organizations who are interested in developing and promoting best practice in the assessment of scholarly research to sign DORA.
Its objectives are:
1. Raise awareness. To call attention to new tools and processes in research assessment and the responsible use of metrics that align with core academic values and promote consistency and transparency in decision-making.
2. Facilitate implementation. To aid development of new policies and practices for hiring, promotion, and funding decisions.
3. Catalyze change. To spread research assessment reform broadly by working across scholarly disciplines and globally.
4. Improve equity. To call for broader representation of researchers in the design of research assessment practices that directly address the structural inequalities in academia.
How Journals and Publishers Can Help to Reform Research Assessment?
ACEM monthly editorial duty hour
Once a month our Managing Editor, Marek Misiak, is awaiting you at a Google Meets meeting. He will answer all your questions and clarify problematic issues.
The meeting take place on the first Thursday of each month (beginning in April 2023) between 9:30 and 10:30 CET. You can enter the meeting using the following URL:
The only prerequisite is a Google account – without it you will not be able to log in to the meeting.
The dates of the meetings in 2023 are as follows: April 6, May 4, June 1, July 6, August 3, September 7, October 5, November 2 and December 7.
Using bar and line graphs to present statistical data
Figures in scientific publications are critically important because they often show the data supporting key findings. However, small sample size studies rarely include scatterplots, box plots and histograms that allow readers to critically evaluate continuous data. Most papers present continuous data as bar and line graphs. This is problematic, as many different data distributions can lead to the same bar or line graph. The full data may suggest different conclusions from the summary statistics.
This issue is concisely discussed [with examples] in this paper:
https://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.1002128
It is also worthy to read this paper:
https://www.nature.com/articles/520589f
Increase of article-processing charge
All original papers and meta-analyses submitted after February 1, 2023, 00:01 CET, and not exempt from article processing charge (APC) will be subject to a higher APC if accepted for publication. The new fee is 990 EUR / 4900 PLN for original papers and meta-analyses. The publication fee for reviews, research-in-progress (RIP) papers and research letters does not change and remains as follows:
700 EUR / 3500 PLN for reviews;
350 EUR / 1750 PLN for research-in-progress (RIP) papers;
350 EUR / 1750 PLN for research letters.
All original papers and meta-analyses submitted until January 31, 2023, 23:59 CET are subject to the previous amount of the fee (700 EUR / 3000 PLN for original papers, met-analyses and reviews, 350 EUR / 1500 PLN for research letters).
Chinese New Year
兔年大吉! 前兔似锦!
During the Year of the Tiger, we published over 100 high-quality scientific papers submitted by Chinese researchers – and we want more! Therefore, we want to encourage you to publish in “Advances in Clinical and Experimental Medicine” – a journal which publishes high-quality original articles, research-in-progress, research letters and systematic reviews and meta-analyses of recognized scientists that deal with all clinical and experimental medicine. The journal is published monthly (12 issues per year) – each issue is released on the last day of the respective month. Most articles are published as ahead of print articles before the scheduled release date of the issue they are assigned to.
We offer professional peer review and linguistic editing, presence in the most important scientific databases (PubMed/Medline, Scopus, Science Citation Index Expanded, Embase etc.), and – last but not least – low APC. Our present impact factor is 2.1 and is steadily rising. We are also an open access journal, so your research would be available for members of scientific community worldwide without any financial or formal barriers.
Join our team of authors and reviewers, and participate fully in global knowledge circulation!
Support from the Ministry
Our journal has received financial support within the “Social Responsibility of Science – Support for Academic Publishing” project based on agreement No. RCN/SP/0584/2021 from the resources of Ministry of Science and Higher Education.
Scientific Social Responsibility programs – Science for All – constitute an important offer for society. They aim at identifying opportunities, supporting dialogue and engaging large groups of stakeholders. Science for All increases the efficiency and effectiveness of activities in science and research areas, implementing the University’s Third Mission.
Not only does Science for All popularize and disseminate science but also stimulates cognitive curiosity and integrate local communities with academia. The Science for All initiatives are supposed to equal educational opportunities and reach those parts of the country where academic and scientific activity has not existed so far.
How to create an account in Editorial System?
The editorial staff of Advances in Clinical and Experimental Medicine is aware that creating an account in the Editorial System [https://www.editorialsystem.com/acem/], which we use, i.a., for manuscript and review submission, is not always easy from the perspective of authors and peer reviewers. Therefore, we offer a guideline in PDF linked below, which presents the whole process using screenshots and comments.
Guideline – how to create an account in Editorial System
Should any problems arise, do not hesitate to contact the managing editor of Advances in Clinical and Experimental Medicine – Marek Misiak [marek.misiak@umw.edu.pl]. He will establish an account for you and will only need to log in.
Graphical abstracts
Beginning with the 1/2023 issue, the journal Advances in Clinical and Experimental Medicine requires also visual abstracts (also known as graphical abstracts) for papers accepted for publication.
Such abstract is a single, concise, pictorial and visual summary of the main findings of the article. It should be a figure that is specially designed for the purpose, which captures the content of the article for readers at a single glance. Authors must provide an original image that clearly represents the work described in the paper. Graphical abstracts should be submitted as a separate file in the submission system as Figure 0. For ease of browsing, the graphical abstract should have a clear start and end, preferably "reading" from top to bottom or left to right. Try to reduce distracting and cluttering elements as much as possible. No additional text, outline or synopsis should be included. Any text or label must be part of the image file. Please do not use unnecessary white space or a heading “graphical abstract” within the image file. The text within the graphical abstract should be used sparingly. The graphical abstract for a paper should not include data items of any type; all the content should be in a graphical form.
Allowed data formats: for VECTOR graphics (charts, diagrams, etc.) – pdf, eps, ai, cdr (if the graphic was created using MS Office programs, source files of a given program are very helpful: doc, docx, ppt, pptx, xls, xlsx); for BITMAP graphics (photos, screenshots) – tif, jpg, png, bmp (min. 1200 pixels of the base in the drawing with the width of one column and 2400 for the width of two columns). The minimal resolution of tif, jpg and png files is 300 dpi. Regarding text within the graphical abstract, its size should be 12–16 points (smaller fonts will not be legible online).
The editorial office of Adv Clin Exp Med does not offer graphical or DTP services – the authors have to provide graphical abstracts in a finished form. Neither one of the figures from the manuscript (e.g., a graph or diagram) nor a PRISMA diagram cannot simultaneously serve as a graphical abstract).
More on how to prepare visual abstract (with examples): https://www.elsevier.com/authors/tools-and-resources/visual-abstract
More on how to prepare graphical abstract, more examples and an online tool to prepare it: https://mindthegraph.com/blog/create-effective-graphical-abstract/
Should any questions arise, do not hesitate to contact the editorial office. Please send the graphical abstracts via e-mail at the e-mail address marek.misiak@umw.edu.pl.
DOAJ
The editorial office of Advances in Clinical and Experimental Medicine proudly informs that the journal has been accepted into Directory of Open Access Journals (DOAJ) and is indexed in this database. This fact confirms our integrity regarding publication ethics and clear rules for authors.
Our support for Ukraine
The 19th-century Ukrainian Romantic poet, Taras Shevchenko (1814–1861), wrote this poem in 1845:
Як умру, то поховайте
Мене на могилі
Серед степу широкого
На Вкраїні милій,
Щоб лани широкополі,
І Дніпро, і кручі
Було видно, було чути,
Як реве ревучий…
When I die, let me rest
Buried in a grave
On the wide steppe
In my dear Ukraine,
Where the broad-rimmed fields
And the Dnipro, and cliffs
Are visible, so I can hear
How the roaring roars.
Shevchenko’s “Testament” remains an anthem for Ukrainian national sentiment. It’s a poem of longing, written by a man who is separated from his native rivers, cliffs, and steppe. It shows off the alliterative power of the Ukrainian language.
After a Russian-language Odessa poet, Boris Khersonsky, began to write poems in Ukrainian in solidarity with the 2013–2014 Maidan “Revolution of Dignity,” he wrote a version of “Testament.”
Як умру, то не ховайте
мене на могилi.
Хай несуть мене до неба
полум’янi хвилi.
Хай розвiє сiрий попiл
повiтряна сила,
бо йому, щоб полетiти,
не потрiбнi крила.
Бо нема землi на свiтi,
щоб назвав своею.
When I die, don’t let me rest
Buried in a grave
Let the waves of fire carry
Me up to the sky.
Let the windy powers dispel
The gray ash, let it scatter
For, no wings are necessary
For this ash to fly.
For no land in all the world
Can be called my own.
